Cargando…
Drug resistance in glioblastoma: are persisters the key to therapy?
Glioblastoma (GBM) represents the main form of brain tumors in adults, and one of the most aggressive cancers overall. The treatment of GBM is a combination of surgery (when possible), chemotherapy (usually Temozolomide, TMZ) and radiotherapy (RT). However, despite this heavy treatment, GBM invariab...
Autores principales: | Oliver, Lisa, Lalier, Lisenn, Salaud, Céline, Heymann, Dominique, Cartron, Pierre François, Vallette, François M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992484/ https://www.ncbi.nlm.nih.gov/pubmed/35582442 http://dx.doi.org/10.20517/cdr.2020.29 |
Ejemplares similares
-
Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress
por: Olivier, Christophe, et al.
Publicado: (2021) -
Bcl-2 Family Members and the Mitochondrial Import Machineries: The Roads to Death
por: Lalier, Lisenn, et al.
Publicado: (2022) -
The DNMT1/PCNA/UHRF1 disruption induces tumorigenesis characterized by similar genetic and epigenetic signatures
por: Pacaud, Romain, et al.
Publicado: (2014) -
Targeting Metabolism to Induce Cell Death in Cancer Cells and Cancer Stem Cells
por: Pecqueur, Claire, et al.
Publicado: (2013) -
TOM20-mediated transfer of Bcl2 from ER to MAM and mitochondria upon induction of apoptosis
por: Lalier, Lisenn, et al.
Publicado: (2021)